Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer

Modern Pathology

Volumn 18, Issue 5, 2005, Pages 673-680

  Fadare, Oluwole ^a   Mariappan, M Rajan ^a,b   Hileeto, Denise ^a   Wang, Sa ^a,c   McAlpine, Jessica N ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Endometrial cancer; Pelvic washing; Peritoneal washing; Surgical staging

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; DIAGNOSTIC VALUE; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN CELL; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 18744372754     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800342     Document Type: Article

References (72)

1. Greene FL, Page DL, Fleming ID, et al. Purposes and principles of staging. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, (eds). AJCC Cancer Staging Handbook, 6th edn. Springer-Verlag: New York, 2002;3-14.
2. Boronow RC. Surgical staging of endometrial cancer: evolution, evaluation and responsible challenge-a personal perspective. Gynecol Oncol 1997;66:179-189.
3. Benedet JL, Pecorelli S. Why cancer staging? Int J Gynaecol Obstet 2003;83(Suppl 1):3.
4. Kosary CL. FIGO stage, histology, histological grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-1987 SEER cases of cancer of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
5. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004;35:649-662.
6. Abeler VM, Kjorstad KE. Endometrial carcinoma in Norway. A study of a total population. Cancer 1991; 67:3093-4003.
7. Wolfson A, Sightler S, Markoe A, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-146.
8. Gal D, Recio FO, Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in endometrial carcinoma. Cancer 1992;69:200-202.
9. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 2003;83(Suppl 1):79-118.
10. Chen S. Extrauterine spread in endometrial carcinoma clinically confined to the uterus. Gynecol Oncol 1985;21:23-31.
11. Gusberg S. The problem of staging endometrial cancer. Obstet Gynecol 1966;28:305-308.
12. Fanning J, Alvarez P, Tsukada Y, et al. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol Oncol 1991;40: 46-47.
13. Soothill PW, Alcock CJ, MacKenzie IZ. Discrepancy between curettage and hysterectomy histology in patients with stage I uterine malignancy. Br J Obstet Gynecol 1989;96:478-481.
14. Tornos C, Silva EG, el-Nagger A, et al. Aggressive stage 1 grade 1 endometrial carcinoma. Cancer 1992; 70:790-798.
15. Cowles T, Javier F, Masterson B, et al. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 1985;66:413-416.
16. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 1987;60: 2035-2041.
17. Creasman WT, Eddy GL. Recent advances in endometrial cancer. Semin Surg Oncol 1990;6:339-342.
18. Creasman WT. New gynecologic cancer staging. Obstet Gynecol 1990;75:287-288.
19. Keettel WC, Elkins HG. Experience with radioactive colloidal gold in the treatment of ovarian cancer. Am J Obstet Gynecol 1956;71:553-568.
20. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773-781.
21. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
22. Wolfson AH, Sightler SE, Markoe AM, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-146.
23. Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992;47:145-149.
24. Grigsby PW, Perez CA, Kuten A, et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implication of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 1992;22:905-911.
25. Kennedy AW, Webster KD, Nunez C, et al. Pelvic washings for cytologic analysis in endometrial adenocarcinoma. J Reprod Med 1993;38:637-642.
26. Szpak CA, Creasman WT, Vollmer RT, et al. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. Acta Cytol 1981;25:640-646.
27. Soper JT, Creasman WT, Clarke-Pearson DL, et al. Intraperitoneal chromic phosphate P32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 1985;153: 191-196.
28. Kennedy AW, Peterson GL, Becker SN, et al. Experience with pelvic washings with stage I and II endometrial carcinoma. Gynecol Oncol 1987;28:50-60.
29. Mazurka JL, Krepart GV, Lotocki RJ. Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 1988;158: 303-306.
30. Imachi M, Tsukamoto N, Matsuyama T, et al. Peritoneal cytology in patients with endometrial carcinoma. Gynecol Oncol 1988;30:76-86.
31. Konski A, Poulter C, Keys H, et al. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology. Int J Radiat Oncol Biol Phys 1988;14:49-55.
32. Creasman WT, Disaia PJ, Blessing J, et al. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921-929.
33. Yazigi R, Piver MS, Blumenson L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol 1983;62:359-362.
34. Ide P. Prognostic value of peritoneal fluid cytology in patients with endometrial cancer stage I. Eur J Obstet Gynecol Reprod Biol 1984;18:343-349.
35. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinicalpathologic findings of a prospective study. Obstet Gynecol 1984;63: 825-832.
36. 32P) therapy. Int J Radiat Oncol Biol Phys 1988;15:815-822.
37. Harouny VR, Sutton GP, Clark SA, et al. The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol 1988;72:394-398.
38. Brewington KC, Hughes RR, Coleman S. Peritoneal cytology as a prognostic indicator in endometrial carcinoma. J Reprod Med 1989;34:824-826.
39. McLellan R, Dillon MB, Currie JL, et al. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Surv 1989;44:711-719.
40. Hirai Y, Fujimoto I, Yamauchi K, et al. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol 1989;73:335-338.
41. Lurain JR, Rumsey NK, Schink JC, et al. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1989;74:175-179.
42. Turner DA, Gershenson DM, Atkinson N, et al. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74: 775-780.
43. Grimshaw RN, Tupper WC, Fraser RC, et al. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 1990;36:97-100.
44. Zuna RE, Behrens A. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst 1996;88:980-987.
45. Mathew S, Erozan YS. Significance of peritoneal washings in gynecologic oncology. The experience with 901 intraoperative washings at an academic center. Arch Pathol Lab Med 1997;121:604-606.
46. Gu M, Barakat RR, Thaler HT, et al. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 2000;44:783-789.
47. Ebina Y, Hareyama H, Sakuragh N, et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 1997;82:244-248.
48. Vecek N, Marinovic T, Ivic J, et al. Prognostic impact of peritoneal cytology in patients with endometrial carcinoma. Eur J Gynaecol Oncol 1993;14: 380-385.
49. Obermair A, Geramou M, Tripcony L, et al. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 2001;164:105-110.
50. Descamps P, Calais G, Moire C, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997;64:54-58.
51. Milosevic MF, Dembo AJ, Thomas GM. The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma. Int. J Gynecol Cancer 1992;2: 225-235.
52. Kashimura M, Sughihara K, Toki N, et al. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 1997;67: 285-290.
53. Preyer O, Obermair A, Formann E, et al. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol 2002;86:269-273.
54. Hernandez E, Rosenshein N, Dillon MB, et al. Peritoneal cytology in stage I endometrial cancer. J Natl Med Assoc 1985;77:799-803.
55. Burrell MO, Franklin III EW, Powell JL. Endometrial cancer: evaluation of spread and follow-up one hundred eighty-nine patients with Stage I or Stage II disease. Am J Obstet Gynecol 1982;144:181-185.
56. Takeshima N, Nishida H, Tabata T, et al. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol 2001;82:470-473.
57. Santala M, Talvensaari-Mattila A, Kauppila A. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 2003;23: 3097-3103.
58. Benedet JL, Hacker NF, Ngan HYS. Cancer of the corpus uteri In: Benedet JL, Hacker NF, Ngan HYS (eds). Staging Classifications and Clinical Practice Guidelines of Gynaecologic Cancers, 2nd edn. http://www.figo.com, Accessed 06/12/04.
59. Hirai Y, Takeshima N, Kato T, et al. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol 2001;97:725-728.
60. Sutton GP. Peritoneal cytology in endometrial carcinoma. Cancer Treat Res 1989;49:41-52.
61. Tarin D. Cancer metastasis. In: Peckham M, Pinedo H, Veronesi U (eds). Oxford Textbook of Oncology. Oxford University Press: Oxford, 1995, pp 118-132.
62. Fidler IJ. Molecular biology of cancer: invasion and metastasis. In: DeVita Jr VT, Hellmann S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 5th edn. Lippincott-Raven Publishers: Philadelphia, 1997, pp 135-152.
63. Abati A, Liotta LA. Looking forward in diagnostic pathology. The molecular superhighway. Cancer 1996;78:1-3.
64. Melichar B, Freedman RS. Immunology of the peritoneal cavity: relevance for host-tumor relation. Int J Gynecol Cancer 2002;12:3-17.
65. Chen LM, Berek JS. Staging and treatment of endometrial cancer. http://www.uptodateonline.com, Accessed 06/11/04.
66. Lurain JR, Rice BL, Rademaker AW, et al. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63-69.
67. Zaino RJ, Kurman RJ, Diana KL, et al. Pathologic models to predict outcome for women with endometrial cancer. The importance of the distinction between surgical stage and clinical stage - a gynecologic oncology group study. Cancer 1996;77:1115-1121.
68. Lurain JR. The significance of positive peritoneal cytology in endometrial cancer [editorial]. Gynecol Oncol 1992:46:143-144.
69. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1990;3:120-128.
70. Lee KR, Belinson JL. Recurrence in noninvasive endometrial carcinoma, Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 1991;15: 965-973.
71. Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma. Am J Surg Pathol 2000;24: 797-806.
72. Chen MD, Karlan BY, Muderspach LI, et al. Is positive peritoneal cytology sufficient for stage IIIA endometrial cancer? In: Abstracts of Current Clinical and Basic Investigation of the 40th Annual Clinical Meeting April 27-30, 1992. American College of Obstetricians and Gynecologists Abstracts, Washington DC, 1992, p 13.